Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection
暂无分享,去创建一个
Ahmed M. Hashem | M. Emad M. Rasmy | Khaled M. Wahba | Olfat G. Shaker | K. Wahba | A. Hashem | M. E. Rasmy | O. Shaker | Olfat G. Shaker | Ahmed M. Hashem | Khaled M. Wahba
[1] Patrick Shannon,et al. Business Statistics: A Decision-Making Approach , 1981 .
[2] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[3] Massimo Pinzani,et al. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography , 2008, Nature Clinical Practice Gastroenterology &Hepatology.
[4] Mohamed Abdel-Hamid,et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[6] Giorgio Palù,et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. , 2005, Journal of hepatology.
[7] Dumitru Dumitrescu,et al. An Evolutionary Approximation for the Coefficients of Decision Functions within a Support Vector Machine Learning Strategy , 2009, Foundations of Computational Intelligence.
[8] John P. Iredale,et al. Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.
[9] Qinghui Wang,et al. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers , 2010, BMC infectious diseases.
[10] D. Roulot,et al. Transforming growth factor β and the liver , 2001 .
[11] E. Schiff,et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology , 2000, Journal of gastroenterology and hepatology.
[12] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[13] M. Abdel-hamid,et al. Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. , 1997, Journal of human virology.
[14] S Chevret,et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial , 2002, Journal of viral hepatitis.
[15] A. Way,et al. Egypt Demographic and Health Survey 2000. , 2009 .
[16] Daniela Manuc,et al. Methods for Data Selection in Medical Databases: The Binary Logistic Regression -Relations with the Calculated Risks , 2008 .
[17] Y. Alp Aslandogan,et al. Evidence combination in medical data mining , 2004, International Conference on Information Technology: Coding and Computing, 2004. Proceedings. ITCC 2004..
[18] N. Afdhal,et al. Perspectives on Fibrosis Progression in Hepatitis C: An à la Carte Approach to Risk Factors and Staging of Fibrosis , 2010, Antiviral therapy.
[19] Man-Fung Yuen,et al. Viral hepatitis B , 2003, The Lancet.
[20] Fernando Martin-Sanchez,et al. An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients. , 2011, The Journal of infection.
[21] Gamal Esmat,et al. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. , 2007, Journal of hepatology.
[22] Reza Malekzadeh,et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B , 2005, BMC gastroenterology.
[23] Yoram Singer,et al. Reducing Multiclass to Binary: A Unifying Approach for Margin Classifiers , 2000, J. Mach. Learn. Res..
[24] F. Degos,et al. Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.
[25] Nigel Crook,et al. Using input parameter influences to support the decisions of feedforward neural networks , 1999, Neurocomputing.
[26] D M Bissell,et al. Transforming growth factor beta and the liver. , 2001, Hepatology.
[27] N. Afdhal,et al. Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.
[28] Florin Gorunescu,et al. Data Mining Techniques in Computer-Aided Diagnosis: Non-Invasive Cancer Detection , 2007 .
[29] Y Ikuta,et al. Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[30] Ruxandra Stoean,et al. Evolutionary-driven support vector machines for determining the degree of liver fibrosis in chronic hepatitis C , 2011, Artif. Intell. Medicine.
[31] HiroshiSakugawa,et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease , 2005 .
[32] S. Friedman. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.
[33] Albert Tran,et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus , 2005, Comparative hepatology.
[34] Samer S El-Kamary,et al. Role of liver biopsy in management of chronic hepatitis C: A systematic review , 2002, Hepatology.
[35] Bruno Crémilleux,et al. Search for factors estimating the stage of liver fibrosis based on the discovery of meaningful clusters , 2002 .
[36] Jaideep Srivastava,et al. Feature Mining for Prediction of Degree of Liver Fibrosis , 2005, AMIA.